DFMO increases survival for children with high risk neuroblastoma, study finds

New research shows the positive results of a phase II clinical trial using the oral medication DFMO to prevent relapse in children with High Risk Neuroblastoma (HRNB).

from Latest Science News -- ScienceDaily https://ift.tt/2Nkvr4C

Comments

Popular posts from this blog

Jared Leto Was Responsible for the "We Live in a Society" Line in the 'Zack Snyder's Justice League' Trailer - /FILM

How to keep Amazon, Apple, and Google from listening to your Alexa, Siri, and Assistant recordings - TechHive

New insights into the structure of a killer protein